Page last updated: 2024-11-05

n-propyl disulfide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

n-Propyl disulfide is an organic compound with the formula CH3CH2CH2SSCH2CH2CH3. It is a colorless liquid with a pungent odor. It is used as a flavoring agent and as an intermediate in the synthesis of other chemicals. n-Propyl disulfide is found in garlic, onions, and other alliums. It is also a component of the aroma of certain cheeses. n-Propyl disulfide is synthesized by the reaction of n-propyl bromide with sodium disulfide. n-Propyl disulfide has been shown to have antimicrobial activity. It is also a potent inhibitor of the enzyme glutathione reductase. n-Propyl disulfide is studied for its potential use in the treatment of cancer. '

n-propyl disulfide: major flavor component of onions; non-nitrogenous, pungent volatile oil [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dipropyl disulfide : An organic disulfide where the alkyl groups specified are propyl. It is a component of the essential oils obtained from Allium. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12377
CHEBI ID45758
SCHEMBL ID113363
MeSH IDM0122531

Synonyms (52)

Synonym
fema no. 3228
propyldithiopropane
ai3-37201
einecs 211-079-8
nsc 75122
disulfide, dipropyl
di-n-propyl disulfide
nsc75122
nsc-75122
4,5-dithiaoctane
propyl disulfide
inchi=1/c6h14s2/c1-3-5-7-8-6-4-2/h3-6h2,1-2h
629-19-6
dipropyl disulfide
n-propyl disulfide
C08373
propyl disulfide, >=97%, fg
1-(propyldisulfanyl)propane
dipropyl disulphide
1,1'-dithiodipropane
CHEBI:45758
dipropyl disulfide, 98%
D0932
A834090
cas-629-19-6
dtxcid302096
tox21_301499
NCGC00255274-01
dtxsid2022096 ,
i7k169j70f ,
unii-i7k169j70f
FT-0625200
AKOS015897437
propyl disulfide [fhfi]
fema no. 4577, dipropyl-
n-propyldisulfide
1-propyldisulfanyl-propane
SCHEMBL113363
di-n-propyldisulfide
(n-c3h7s)2
mfcd00009378
fema 3228
1,1'-disulfanediyldipropane
n-propyl-disulfide
CS-0259501
Q1227317
1,2-dipropyldisulfane
E79213
AS-56755
nsc797350
nsc-797350
EN300-7352631

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Whereas the bioavailability of DPDS was very low (0."( Disposition and metabolism of dipropyl disulphide in vivo in rat.
Germain, E; Semon, E; Siess, MH; Teyssier, C, 2008
)
0.35

Dosage Studied

ExcerptRelevanceReference
" Dipropenyl disulfide was much less active, while little effect on enzyme activity was seen in animals dosed with dipropyl disulfide."( Relative activities of organosulfur compounds derived from onions and garlic in increasing tissue activities of quinone reductase and glutathione transferase in rat tissues.
Munday, CM; Munday, R, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organic disulfideCompounds of structure RSSR in which R and R' are organic groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.70)18.7374
1990's8 (29.63)18.2507
2000's11 (40.74)29.6817
2010's4 (14.81)24.3611
2020's3 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.05 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index5.34 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.70%)6.00%
Case Studies1 (3.70%)4.05%
Observational0 (0.00%)0.25%
Other25 (92.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]